Combination therapy for pain management in inflammatory arthritis (rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, other spondyloarthritis)

Keyphrases

• Rheumatoid Arthritis 100%
• Combination Therapy 100%
• Non-steroidal Anti-inflammatory Drugs (NSAIDs) 100%
• Pain Management 100%
• Ankylosing Spondylitis 100%
• Inflammatory Arthritis 100%
• Spondyloarthritis 100%
• Psoriatic Arthritis 100%
• Monotherapy 90%
• Opioids 50%
• No Significant Difference 30%
• Risk of Bias 30%
• Analgesic 30%
• Disease-modifying Antirheumatic Drugs (DMARDs) 30%
• Neuromodulators 30%
• High Risk 20%
• Persistent Pain 20%
• Pain Treatment 20%
• Phenylbutazone 20%
• Disease Suppression 20%
• High Dose 10%
• Randomized Clinical Trial 10%
• Subgroup Analysis 10%
• Meta-analysis 10%
• Selection Criteria 10%
• Absence of Evidence 10%
• Controlled Experiment 10%
• Inclusion Criteria 10%
• MEDLINE 10%
• Embase 10%
• Antidepressants 10%
• Pain Scale 10%
• Paracetamol 10%
• Drug Therapy 10%
• Cochrane Library 10%
• Search Strategy 10%
• Osteoarthritis 10%
• Anticonvulsant 10%
• Cochrane Central Register of Controlled Trials 10%
• Mixed Population 10%
• European League against Rheumatism (EULAR) 10%
• Adalimumab 10%
• Methotrexate 10%
• Etanercept 10%
• Infliximab 10%
• Review Authors 10%
• Conflicting Results 10%
• Conference Proceedings 10%
• American College of Rheumatology 10%
• Aspirin 10%
• Opioid Analgesics 10%
• Hydroxychloroquine 10%
• Optimal Therapy 10%
• Biologic Therapy 10%
• Additional Therapy 10%
• Muscle Relaxant 10%
• Leflunomide 10%
• Inadequate Analgesia 10%
• Sulfasalazine 10%
• Background Therapy 10%
• Psoriatic Spondyloarthritis 10%
• Extracted Data 10%

INIS

• therapy 100%
• inflammation 100%
• arthritis 100%
• management 100%
• pain 100%
• ankylosing spondylitis 100%
• drugs 76%
• patients 29%
• diseases 23%
• people 23%
• analgesics 23%
• data 17%
• values 17%
• control 17%
• risks 17%
• doses 11%
• comparative evaluations 11%
• safety 11%
• suppression 11%
• interventions 11%
• populations 11%
• inclusions 11%
• information 5%
• clinical trials 5%
• reviews 5%
• muscles 5%
• libraries 5%
• conferences 5%
• adults 5%
• antidepressants 5%
• colleges 5%
• proceedings 5%
• anticonvulsants 5%
• methotrexate 5%
• aspirin 5%

Pharmacology, Toxicology and Pharmaceutical Science

• Rheumatoid Arthritis 100%
• Combination Therapy 100%
• Psoriatic Arthritis 100%
• Ankylosing Spondylitis 100%
• Spondylarthritis 100%
• Inflammatory Arthritis 100%
• Monotherapy 75%
• Non-Steroidal Anti-Inflammatory Drug 75%
• Analgesic Agent 25%
• Disease Modifying Antirheumatic Drug 16%
• Phenylbutazone 16%
• Diseases 16%
• Randomized Controlled Trial 8%
• Paracetamol 8%
• Osteoarthritis 8%
• Acetylsalicylic Acid 8%
• Population Study 8%
• Antidepressant 8%
• Infliximab 8%
• Adalimumab 8%
• Anticonvulsive Agent 8%
• Pharmacotherapy 8%
• Randomized Clinical Trial 8%
• Controlled Clinical Trial 8%
• Rheumatic Disease 8%
• Sulfasalazine 8%
• Methotrexate 8%
• Etanercept 8%
• Leflunomide 8%
• Muscle Relaxant Agent 8%
• Narcotic Analgesic Agent 8%
• Hydroxychloroquine 8%